# Comparison of Three Methods for Early Detection of Breast Cancer

> **NCT03954015** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 3 (actual)

## Conditions studied

- Proliferative Breast Disease

## Interventions

- **DIAGNOSTIC_TEST:** Contrast Enhanced imaging
- **DRUG:** Lumason

## Key facts

- **NCT ID:** NCT03954015
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-15
- **Primary completion:** 2020-06-30
- **Final completion:** 2021-10-05
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2022-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954015, "Comparison of Three Methods for Early Detection of Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03954015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*